News of the latest advancements in strategies and treatment against many rare diseases comes out of the pharmaceutical company named Amicus Therapeutics. Based in Cranbury‚ New Jersey‚ with a second research facility in Southern California‚ the company is making gains in the pharmaceutical industry on the heel of announcements that the Food and Drug Administration (FDA) is planning to accept a New Drug Application (NDA) for the new drug Migalastat which was developed by Amicus Therapeutics. An
Premium Medicine Pharmacology Health care
Danish Parvez Ahmed Saeed Khan Chandni Kumari Anum Ali Junejo Executive Summary This is a research on GlaxoSmithKline a pharmaceutical concern has been conducted to primarily understand two aspects. First is to comprehend the current strategy of the company and second is to suggest an apt strategy to the company after analyzing the conditions of the pharmaceutical industry and the political‚ social and legal environment at large. The report would
Premium Financial ratio Financial ratios Pharmaceutical industry
[pic] A Report on The Training and Development section of Corporate Human Resource Department of Beximco Pharmaceuticals Submitted by- Mahmuda Rahman ID#082011089 Tahmina Akter ID#082011063 Khalika Aktar ID#082011041 Rezwana Ferdous ID#082011058 Riva Afros ID#082011076 Submitted to- Farhana Rashid Assistant Professor ULAB School of Business University of Liberal Arts Bangladesh (ULAB) Date- 18 August 2010 Acknowledgement We are very grateful to our course (Human
Premium Human resource management Human resources Management
Factors Affecting Physician’s Behavior to Prescribe Generic Medicines in Pharmaceutical sector in egypt By Mohamed Helal Al-Siufy Supervised by Dr. Ramy William This paper was submitted in partial fulfillment of the requirements for the degree of MASTER OF BUSINESS ADMINISTRATION (MBA) At Victoria School of Management Switzerland March 2014 CHAPTER 1 INTRODUCTION 1.1 OVERVIEW Researchers argue that generics became widely prescribed by physicians especially since
Premium Generic drug Food and Drug Administration Pharmaceutical industry
Khushal Malik – 28 Sharad Singh – 49 PHARMACEUTICAL INDUSTRY – Global Trend • • • • Mainly concentrated in the United States‚ Europe‚ and Japan Developing a drug from discovery to launch took 10 to 12 years. Cost of development of drug is between $500-$800 million. Drugs were strictly controlled by government agencies: o Food and Drug Administration (FDA) – USA‚ o CPMP – Europe o MHW – Japan o DPCO & Indian Patent Act - India • Size of industry : USD 960 billion in 2012. • Few Firms
Premium Generic drug Pharmaceutical industry Ranbaxy Laboratories
Analysis……………………………………………………………………………4 Industry Analysis………………………………………………………………………….5 Product and Process Analysis…………………………………………………………….7 Company Strategy………………………………………………………………………...9 Recommendations………………………………………………………………………..11 Conclusion………………………………………………………………………………..13 EXECUTIVE SUMMARY This case outlines the difficulty faced by Eli Lilly‚ a pharmaceutical company’s decision as to whether they should
Premium Pharmaceutical industry Drug discovery Clinical trial
Adopted With A View To Encourage Fair Competition At The International Level‚ But Trips Rules Tilt The Balance In Favour Of Imperfect Competition With Each Country And Exacerbates International Inequalities. (Discussion With Reference To Pharmaceutical Industry) Name of Lecturer : Rajendran K S Name of Student : Nilesh Singh Date of Submission : 6 May 2011 Table of Contents 1. | Introduction | 3 | | 1.1 Main Objective of This Essay | 3 | 2. | Role of TRIPs in International
Premium Pharmaceutical industry Patent Generic drug
Hoover ’s Company Records. Merck and Co.‚Inc. (2012). Retrieved from http://www.hoovers.com/company/Merck__Co_Inc/rrytji-1-1njhw5.html Hoover ’s Company Records CNN.com. (2011). Fortune 500 2011: Industry: Pharmaceuticals. Retrieved from http://money.cnn.com/magazines/fortune/fortune500/2011/industries/21/index.html Merck.com NYSE (2012). Retrieved from: http://www.advfn.com/p.php?pid=financials&symbol=NYSE%3AMRK Pfizer.com US Department of Treasury. (2012). Retrieved from: http://www.treasury.
Premium Pharmaceutical industry Pharmacology Generic drug
Marketing Strategies in the Competition between Branded and Generic Antibiotics (A) Clamoxyl in 1996 02/2007-5057 This case was prepared by Pierre Chandon‚ Assistant Professor of Marketing at INSEAD‚ Olivier Kovarski‚ Professor of Marketing at ESC Normandie‚ Jacques Lendrevie‚ Professor of Marketing at HEC‚ Sarah Spargo‚ Research Associate at INSEAD‚ and Marc Vanhuele‚ Associate Professor of Marketing at HEC‚ as the basis for class discussion rather than to illustrate either effective
Premium Generic drug Pharmaceutical industry Antibiotic resistance
CHANAKYA NATIONAL LAW UNIVERSITY‚ PATNA Economics-II Project on:- IPR and access to medicines in india Submitted To: Mrs. Shivani Mohan (Faculty for Economics) Submitted By: Somya Priyadarshini Roll No.: 471 Semester: IVth ‚ 2nd Year. ACKNOWLEDGEMENT The present project
Premium Patent Patent law Pharmaceutical industry